Yi-Ying Wu

651 citations
22 papers · 478 indexed · h-index 12
Topics
Virus-based gene therapy research (2 papers)Peptidase Inhibition and Analysis (2 papers)Ubiquitin and proteasome pathways (2 papers)

In The Last Decade

Yi-Ying Wu

20 papers receiving 473 citations

Peers

Yi-Ying Wu
Comparison fields: 5 of 94
  • Molecular Biology 295
  • Cancer Research 151
  • Oncology 93
  • Genetics 59
  • Immunology 44
Replace Maria Bellenghi with:
Maria Bellenghi Italy
Nao Nishida‐Aoki Japan
Jessica Lamberti Italy
Ruibo Wang China
Sibylle Dames Germany
Ruth M. Escalona Australia
Lijun Mao China
Funian Lu China
Amy Baumann United States
Brittany D. Jenkins United States
Yi-Ying Wu relative to Maria Bellenghi Italy Maria Bellenghi's profile →
Citations per field
00.5×1.5×
Maria Bellenghi · 1×
Citations per year

Countries citing papers authored by Yi-Ying Wu

Since Specialization
Citations

This map shows the geographic impact of Yi-Ying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Ying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Ying Wu more than expected).

Fields of papers citing papers by Yi-Ying Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Ying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Ying Wu. The network helps show where Yi-Ying Wu may publish in the future.

Co-authorship network of co-authors of Yi-Ying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Ying Wu. A scholar is included among the top collaborators of Yi-Ying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Ying Wu. Yi-Ying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 37
4 0
5 14
6 41
7
CASZ1 promotes migration, invasion, and metastasis of lung cancer cells by controlling expression of ITGAV.
3
8 6
9 15
10 16
11 14
12 8
13 6
14 4
15 2
16 30
17 26
18 86
19 112
20 17

About Yi-Ying Wu

Yi-Ying Wu is a scholar working on Neuropsychology and Physiological Psychology, Cancer Research and Immunology and Allergy, having authored 22 papers that have together received 478 indexed citations. Recurring topics across this work include Virus-based gene therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (151 citations), Molecular Biology (295 citations) and Oncology (93 citations). Yi-Ying Wu has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Tse‐Ming Hong, Yuh‐Ling Chen, I‐Shan Hsieh, Kung‐Chao Chang, Pan‐Chyr Yang, Hung‐Jen Liu, Jiaen Wu, Wen‐Yann Yeh, Ren-Hau Li and Yih‐Leong Chang. Their work appears in journals such as Cancer Research, Journal of Virology and Inorganic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026